Alterations of Serum Inflammatory Cytokines in Postmenopausal Osteoporosis Patients Treated with Human Parathyroid Hormone (1–34)

Research in Molecular network and mechanism of chondrocytes miR24 associated with osteogenesis in senile ossification of ligamentum flavum

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1800018858

Enrollment

Unknown

Registered

2018-10-14

Start date

2018-10-01

Completion date

Unknown

Last updated

2018-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoporosis fracture

Interventions

Case series:Daily subcutaneous injections of teriparatide (PTH1-34)20ug,plus daily oral calcium 1000 mg and vitamin D 800 IU

Eligibility

Sex/Gender

Female

Age

50 Years to 90 Years

Inclusion criteria

Inclusion criteria: The patients enrolled in this study were confirmed postmenopausal osteoporosis patients at Tianjin Medical University General Hospital.Patients are supposed to have gained daily oral calcium 1000 mg and vitamin D 800 IU since at least three months before enrollment and throughout the study.

Exclusion criteria

Exclusion criteria: 1. Systemic diseases, such as secondary osteoporosis and significant renal or hepatic dysfunction, etc. 2. Contraindications for drugs, such as drug allergy and hypercalcemia,etc.

Design outcomes

Primary

Measure	Time frame
serum inflammatory cytokines;	—

Countries

China

Contacts

Public ContactXue Yuan

General Hospital of Tianjin Medical University

zyyxueyuan@163.com+86 13512003188

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026